Philipp Harter
- Reproductive Medicine top 0.01%
- Ovarian cancer diagnosis and treatment 259
- Endometriosis Research and Treatment 22
- Obstetrics and Gynecology top 0.05%
- Endometrial and Cervical Cancer Treatments 95
- Uterine Myomas and Treatments 25
- Oncology top 0.2%
- PARP inhibition in cancer therapy 73
- Surgery top 0.5%
- Intraperitoneal and Appendiceal Malignancies 76
- Cancer Research top 1%
-
- BRCA gene mutations in cancer 47
-
- Renal cell carcinoma treatment 29
Philipp Harter
304 papers receiving 12.1k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Reproductive Medicine 8.2k
- Obstetrics and Gynecology 3.4k
- Oncology 5.3k
- Surgery 3.6k
- Cancer Research 1.2k
Countries citing papers authored by Philipp Harter
This map shows the geographic impact of Philipp Harter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Harter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Harter more than expected).
Fields of papers citing papers by Philipp Harter
This network shows the impact of papers produced by Philipp Harter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Harter. The network helps show where Philipp Harter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philipp Harter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 1 | |
| 13 | 2022 | 2 | |
| 14 | 2021 | 8 | |
| 15 | 2021 | 10 | |
| 16 | 2021 | 9 | |
| 17 | 2019 | 6 | |
| 18 | 2018 | 27 | |
| 19 | 2008 | 64 | |
| 20 | [Dermatosis papulosa nigra in Dark Africa]. | 2000 | 0 |
About Philipp Harter
Philipp Harter is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 327 papers that have together received 12.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (259 papers), Endometrial and Cervical Cancer Treatments (95 papers), Intraperitoneal and Appendiceal Malignancies (76 papers), PARP inhibition in cancer therapy (73 papers), BRCA gene mutations in cancer (47 papers), Renal cell carcinoma treatment (29 papers), Uterine Myomas and Treatments (25 papers) and Endometriosis Research and Treatment (22 papers). The work is most often cited by research in Reproductive Medicine (8.2k citations), Obstetrics and Gynecology (3.4k citations) and Oncology (5.3k citations). Philipp Harter has collaborated with scholars based in Germany, Italy and Belgium. Frequent co-authors include Andreas du Bois, Isabelle Ray‐Coquard, Florian Heitz, Ignace Vergote, Alexander Reuß, Jonathan A. Ledermann, Werner Meier, Jacobus Pfisterer, Ursula A. Matulonis and Michael Friedländer. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Gynecological Cancer, Gynecologic Oncology, Annals of Oncology and Archives of Gynecology and Obstetrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.